Shares of Biocon rose nearly 3% after the company’s subsidiary Biocon Pharma received approval for its ANDA for Posoconazole delayedrelease tablets from the U.S. FDA.
biocon share price nse
Biocon Gains On Launch Of Generic Version Of Afinitor In The U.S. Market
Shares of Biocon Ltd. rose 1.45% in intraday trade to Rs 370.06 apiece after the company announced the launch of Everolimus tablets, a generic version of Afinitor in the U.S., thereby expanding its generic formulations portfolio.